Parity and kidney cancer risk: Evidence from epidemiologic studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 12, 2013, Pages 2345-2353

  Guan, Hong Bo ^a   Wu, Qi Jun ^b   Gong, Ting Ting ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CANCER RISK; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; KIDNEY CANCER; LIVE BIRTH; MEDICAL SUBJECT HEADINGS; MEDLINE; NULLIPARA; OUTCOME ASSESSMENT; PARITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; SYSTEMATIC REVIEW;

EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 84890082942     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0759-T     Document Type: Article

References (49)

1. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010;7:245-57.
2. Chow WH, Devesa SS, Warren JL, Fraumeni JJ. Rising incidence of renal cell cancer in the United States. JAMA 1999;281:1628-31.
3. Mathew A, Devesa SS, Fraumeni JJ, Chow WH. Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev 2002;11: 171-8.
4. Wu QJ, Vogtmann E, Zhang W, Xie L, Yang WS, Tan YT, et al. Cancer incidence among adolescents and young adults in urban Shanghai, 1973-2005. PLoS ONE 2012;7:e42607.
5. McLaughlin JK, Lipworth L, Tarone RE, Blot WJ. Renal cancer. In: Shottenfeld D, Fraumeni J, editors. Cancer epidemiology and prevention. 3rd ed. New York, NY: Oxford University Press; 2006. p. 1087-100.
6. Li JJ, Weroha SJ, Davis MF, Tawfik O, Hou X, Li SA. ER and PR in renomedullary interstitial cells during Syrian hamster estrogeninduced tumorigenesis: evidence for receptor-mediated oncogenesis. Endocrinology 2001;142:4006-14.
7. Ramin SM, Vidaeff AC, Yeomans ER, Gilstrap LR. Chronic renal disease in pregnancy. Obstet Gynecol 2006;108:1531-9.
8. Karami S, Daugherty SE, Purdue MP. Hysterectomy and kidney cancer risk: a meta-analysis. Int J Cancer. 2013 Jun 1. [Epub ahead of print].
9. Lipworth L, Tarone RE, Lund L, McLaughlin JK. Epidemiologic characteristics and risk factors for renal cell cancer. Clin Epidemiol 2009;1:33-43.
10. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
11. Chiu HF, Kuo CC, Kuo HW, Lee IM, Yang CY. Parity, age at first birth and risk of death from kidney cancer: a population-based cohort study in Taiwan. Eur J Public Health. 2013 Jun 6. [Epub ahead of print].
12. Karami S, Daugherty SE, Schonfeld SJ, Park Y, Hollenbeck AR, Grubb RR, et al. Reproductive Factors and Kidney Cancer Risk in 2 US Cohort Studies, 1993-2010. Am J Epidemiol 2013;177:1368-77.
13. Purdue MP, Colt JS, Graubard B, Davis F, Ruterbusch JJ, Digaetano R, et al. A case-control study of reproductive factors and renal cell carcinoma among black and white women in the United States. Cancer Causes Control 2011;22:1537-44.
14. Lee JE, Hankinson SE, Cho E. Reproductive factors and risk of renal cell cancer: the Nurses' Health Study. Am J Epidemiol 2009;169:1243-50.
15. Setiawan VW, Kolonel LN, Henderson BE. Menstrual and reproductive factors and risk of renal cell cancer in the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2009;18:337-40.
16. Zucchetto A, Talamini R, Dal Maso L, Negri E, Polesel J, Ramazzotti V, et al. Reproductive, menstrual, and other hormone-related factors and risk of renal cell cancer. Int J Cancer 2008;123:2213-6.
17. Molokwu JC, Prizment AE, Folsom AR. Reproductive characteristics and risk of kidney cancer: Iowa Women's Health Study. Maturitas 2007;58:156-63.
18. Kabat GC, Silvera SA, Miller AB, Rohan TE. A cohort study of reproductive and hormonal factors and renal cell cancer risk in women. Br J Cancer 2007;96:845-9.
19. Lambe M, Lindblad P, Wuu J, Remler R, Hsieh CC. Pregnancy and risk of renal cell cancer: a population-based study in Sweden. Br J Cancer 2002;86:1425-9.
20. Gago-Dominguez M, Castelao JE, Yuan JM, Ross RK, Yu MC. Increased risk of renal cell carcinoma subsequent to hysterectomy. Cancer Epidemiol Biomarkers Prev 1999;8:999-1003.
21. Lindblad P, Mellemgaard A, Schlehofer B, Adami HO, McCredie M, McLaughlin JK, et al. International renal-cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones. Int J Cancer 1995;61:192-8.
22. Chow WH, McLaughlin JK, Mandel JS, Blot WJ, Niwa S, Fraumeni JJ. Reproductive factors and the risk of renal cell cancer among women. Int J Cancer 1995;60:321-4.
23. Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH. Risk factors for renal-cell carcinoma in Denmark. III. Role of weight, physical activity and reproductive factors. Int J Cancer 1994;56:66-71.
24. Cantor KP, Lynch CF, Johnson D. Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 1993;4:505-11.
25. La Vecchia C, Negri E, Franceschi S, Parazzini F. Long-term impact of reproductive factors on cancer risk. Int J Cancer 1993; 53:215-9.
26. Wynder EL, Mabuchi K, Whitmore WJ. Epidemiology of adenocarcinoma of the kidney. J Natl Cancer Inst 1974;53:1619-34.
27. Nicodemus KK, Sweeney C, Folsom AR. Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer 2004;108:115-21.
28. Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 1993;4:101-10.
29. McCredie M, Stewart JH. Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control 1992;3:323-31.
30. Talamini R, Baron AE, Barra S, Bidoli E, La Vecchia C, Negri E, et al. A case-control study of risk factor for renal cell cancer in northern Italy. Cancer Causes Control 1990;1:125-31.
31. Hamling J, Lee P, Weitkunat R, Ambuhl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008;27:954-70.
32. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135:1301-9.
33. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012;175:66-73.
34. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58.
35. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
36. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
37. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
38. Gong TT, Wu QJ, Vogtmann E, Lin B, Wang YL. Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiological studies. Int J Cancer 2013;132:2894-900.
39. Gago-Dominguez M, Castelao JE, Yuan JM, Ross RK, Yu MC. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 2002;13:287-93.
40. Clark SL, Cotton DB, Lee W, Bishop C, Hill T, Southwick J, et al. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol 1989;161:1439-42.
41. Le J, Briggs GG, McKeown A, Bustillo G. Urinary tract infections during pregnancy. Ann Pharmacother 2004;38:1692-701.
42. Concolino G, Lubrano C, Ombres M, Santonati A, Flammia GP, Di Silverio F. Acquired cystic kidney disease: the hormonal hypothesis. Urology 1993;41:170-5.
43. Cavalieri EL, Kumar S, Todorovic R, Higginbotham S, Badawi AF, Rogan EG. Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors. Chem Res Toxicol 2001;14:1041-50.
44. Concolino G, Marocchi A, Conti C, Tenaglia R, Di Silverio F, Bracci U. Human renal cell carcinoma as a hormone-dependent tumor. Cancer Res 1978;38:4340-4.
45. Ronchi E, Pizzocaro G, Miodini P, Piva L, Salvioni R, Di Fronzo G. Steroid hormone receptors in normal and malignant human renal tissue: relationship with progestin therapy. J Steroid Biochem 1984;21:329-35.
46. Azziz R. Reproductive endocrinologic alterations in female asymptomatic obesity. Fertil Steril 1989;52:703-25.
47. Mansour AA, Ajeel NA. Parity is associated with increased waist circumference and other anthropometric indices of obesity. Eat Weight Disord 2009;14:e50-5.
48. Giubertoni E, Bertelli L, Bartolacelli Y, Origliani G, Modena MG. Parity as predictor of early hypertension during menopausal transition. J Hypertens 2013;31:501-7.
49. Taylor JY, Sampson DA, Anderson CM, Caldwell D, Taylor AD. Effects of parity on blood pressure among West African Dogon women. Ethn Dis 2012;22:360-6.